End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.37 USD | -1.69% | -7.15% | +16.46% |
Apr. 30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Bullish |
Resistance | 14.51 | 17.27 | 16.03 |
Spread/Res. | -7.86% | -22.58% | -16.59% |
Spread/Supp. | +3.64% | +53.86% | +21.32% |
Support | 12.90 | 8.690 | 11.02 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ALVO Stock
- Charts Alvotech